Yingying Wang
No. 126, Xiantai Street
Changchun, 130033, China
Changchun, 130033, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Single-Cell RNA Sequencing and Bulk RNA Sequencing Revealed the Interplay Between Intratumoral Heterogeneity and the Tumor Microenvironment in Breast Cancer.
Journal: Cancer medicine
Published: October 08, 2025
Mobile apps, AI, and teletherapy: a comprehensive review of digital mental health tools for nurses.
Journal: Frontiers in public health
Published: August 15, 2025
Corrigendum to "Synthesis and clinical application of new drugs approved by NMPA in 2023" [European Journal of Medicinal chemistry 283 (2025) 117181/EJMECH-d-24-03758].
Journal: European journal of medicinal chemistry
Published: June 11, 2025
Integrated natural enzyme and nanozyme nanoreactor for managing cerebral ischemia-reperfusion injury by regulating neuroimmune microenvironment.
Journal: Colloids and surfaces. B, Biointerfaces
Published: March 31, 2025
New FDA drug approvals for 2024: Synthesis and clinical application.
Journal: European journal of medicinal chemistry
Published: December 06, 2024
Synthesis and clinical application of new drugs approved by NMPA in 2023.
Journal: European journal of medicinal chemistry
Published: November 29, 2024
Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer's Disease via Neuroinflammation and Ferroptosis.
Journal: Journal of Alzheimer's disease : JAD
Published: November 06, 2023
Unveiling Immune-related feature genes for Alzheimer's disease based on machine learning.
Journal: Frontiers in immunology
Published: November 06, 2023
The inhibition of ORMDL3 prevents Alzheimer's disease through ferroptosis by PERK/ATF4/HSPA5 pathway.
Journal: IET nanobiotechnology
Published: October 28, 2022
LncRNA Blnc1 mediates the permeability and inflammatory response of cerebral hemorrhage by regulating the PPAR-γ/SIRT6/FoxO3 pathway.
Journal: Life sciences
Published: May 29, 2020
MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways.
Journal: Cell cycle (Georgetown, Tex.)
Published: July 10, 2019
Last Updated: 09/26/2026